Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids with or without oral glucocorticoids.

Mepolizumab treatment in patients with severe eosinophilic asthma

CANONICA, GIORGIO
2014-01-01

Abstract

Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids with or without oral glucocorticoids.
2014
Administration
Oral
Adolescent
Adult
Aged
Aged
80 and over
Anti-Asthmatic Agents
Antibodies
Monoclonal
Humanized
Asthma
Child
Double-Blind Method
Drug Therapy
Combination
Female
Forced Expiratory Volume
Glucocorticoids
Humans
Injections
Intravenous
Injections
Subcutaneous
Male
Middle Aged
Quality of Life
Questionnaires
Secondary Prevention
Young Adult
Eosinophilia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/32384
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1615
social impact